Evaluation of leishmanicidal effect of Perovskia abrotanoides Karel. Root extract by in vitro leishmanicidal assay using promastigotes of Leishmania major

Pharmacologyonline

Volumn 1, Issue , 2007, Pages 299-303

  Jaafari, Mahmood Reza ^a   Hooshmand, Sana ^b   Samiei, Afshin ^a   Hossainzadeh, Hossein ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antileshamanicidal activity; Cutaneous leishmaniasis; Leishmania major; Perovskia abrotanoides

Indexed keywords

ALCOHOL; AMPHOTERICIN B; DIMETHYL SULFOXIDE; METHANOL; PEROVSKIA ABROTANOIDES EXTRACT; PLANT EXTRACT; SOLVENT; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DETERMINATION; IC 50; IN VITRO STUDY; INCUBATION TEMPERATURE; INCUBATION TIME; LEISHMANIA MAJOR; NONHUMAN; PLANT ROOT; PROMASTIGOTE; SKIN LEISHMANIASIS; SOXHLET EXTRACTION; TRADITIONAL MEDICINE;

EID: 34248550729     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. World, Health Organization. (2001). WHO information by topics or disease. Available at: http://www.who.int/emc/disease/leish/index.html.
2. Dowlati, Y. (1996). Cutaneous leishmaniasis: clinical aspect. Clini. Dermatol. 14: 425-431.
3. Croft, S. L. and Coombs, G. H. (2003). Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 19: 502-508.
4. McGregor, A. (1998). WHO warns of epidemic leishmania. Lancet 351: 575.
5. Rechinger, K.H. (1982). Flora Iranica. Graz-Austria. Akademiche. Druck-U verlagsantalt. 150: 477.
6. Sairafianpour, M., Christensen, J., Staerk, D., Budnik, B.A., Kharazmi, A., Bagherzadeh, K. and Jaroszewski, J.W. (2001). Leishmanicidal, antiplasmodial and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: new source of tanshiones. J. Nat. Pro. 64: 1398-1403.
7. Hosseinzadeh, H. and Amel, S. (2001). Antinociceptive effects of the aerial parts of Perovskia abrotanoides extracts in mice. Med. J. Irn. Hosp. 4: 15-17.
8. Nassiri Asl M, Parvardeh S, Niapour M. and Hosseinzadeh H. (2002). Antinociceptive and anti-inflammatory effects of Perovskia abrotanoides aerial part extracts in mice and rats. J. Med. Plants 3: 25-33.
9. Rahman, Atta-Ur., Choudhary, M. I. and Thomsen, W. J. (2001). Bioassay techniques for drug development. Harwood Academic Publishers, The Netherland, p. 60.
10. Ardehali, S., Moattari, A., Hatam, G.R., Hosseini, S.M. and Sharifi, I. (2000). Characterization of Leishmania isolated in Iran: 1. Serotyping with species monoclonal antibodies. Acta Trop. 75: 301-307.
11. Sajjadi, S.E., Mehregan, I., Khatamsaz, M. and Asghari, G.H. (2005). Chemical composition of the essential oil of Perovskia abroatanoides Karel growing wild in Iran. Flav. Frag. J. 20: 445-446.
12. Morteza-Semnani, K. (2004). The essential oil composition of Perovskia abroatanoides from Iran. Pharmac. Biol. 42: 214-216.
13. Tan, N., Kaloga, M., Radke, O.A., Kederlen, A.F., Oksuz, S., Ulubelen, A. and Kolodziej, H. (2002). Abietane diterpenoids and triterpenoic acids from Salvia cilicica and their antileishmanial activities. Phytochemistry 61: 881-884.